Increase Budget to More Than 20 billion won for New Drug Development

Published: 2001-08-31 07:00:00

Updated: 2001-08-31 07:00:00

Following its demand for the maintenance of an actual transaction redemption system, the Korea Pharmaceutical Manufacturers Association (KPMA) has asked the Government to increase its budget for the development of new drugs.

KPMA Chairman Kim Jeong-Su and Managing Director Shin Seok-Uh visite...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK